Human Gene Therapies: Novel Product Development: Q and A with Celia M. Witten, Ph.D, M.D.

Posted by Patrick McDowell in Health News | Comments Off

Dr. Celia M. Witten, Director of CBER’s Office of Cellular, Tissue and Gene Therapy, answers important questions about FDA’s support of, and role in human gene therapy research.